Capstone Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Capstone Investment Advisors's LMAT Position: Q2 2026 in Review
Capstone Investment Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 5,992 shares — an estimated $654K sold.
Capstone Investment Advisors first reported a position in LMAT in Q1 2026 and held it in 1 quarter. The position peaked at $654K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Capstone Investment Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
- Capstone Investment Advisors sold 5,992 LeMaitre Vascular shares in Q2 2026, an estimated $654K.
- Capstone Investment Advisors first reported a position in LeMaitre Vascular in Q1 2026 and held it in 1 quarter.
- Capstone Investment Advisors's LeMaitre Vascular position peaked at $654K in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.